Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 411

1.

Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.

Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S, Windecker S, Bergmann MW, Klingenberg R, Lüscher TF, Haude M, Rulands D, Butter C, Ullman B, Hellgren L, Modena MG, Pedrazzini G, Henriques JP, Figulla HR, Ferrari M.

Circ Heart Fail. 2013 Jan;6(1):23-30. doi: 10.1161/CIRCHEARTFAILURE.112.967224. Epub 2012 Dec 4.

2.

The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.

Lemaire A, Anderson MB, Lee LY, Scholz P, Prendergast T, Goodman A, Lozano AM, Spotnitz A, Batsides G.

Ann Thorac Surg. 2014 Jan;97(1):133-8. doi: 10.1016/j.athoracsur.2013.07.053. Epub 2013 Oct 1.

PMID:
24090575
3.

Outcome of the impella device for acute mechanical circulatory support.

Lemaire A, Anderson MB, Prendergast T, Stockmaster N, Goodman A, Lozane AM, Batsides G.

Innovations (Phila). 2013 Jan-Feb;8(1):12-6. doi: 10.1097/IMI.0b013e31828e0a8a.

PMID:
23571788
4.

Response to letter regarding article, “percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock results of the Impella-EUROSHOCK registry”.

Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S, Windecker S, Bergmann MW, Klingenberg R, Lüscher TF, Haude M, Rulands D, Butter C, Ullman B, Hellgren L, Modena MG, Pedrazzini G, Henriques JP, Figulla HR, Ferrari M.

Circ Heart Fail. 2013 Jul;6(4):e56. No abstract available.

5.
6.

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A.

J Am Coll Cardiol. 2008 Nov 4;52(19):1584-8. doi: 10.1016/j.jacc.2008.05.065.

7.

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.

Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouvière P, Albat B, Colson P.

Crit Care. 2015 Oct 9;19:363. doi: 10.1186/s13054-015-1073-8.

8.

Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.

Vecchio S, Chechi T, Giuliani G, Lilli A, Consoli L, Spaziani G, Giannotti F, Margheri M.

Minerva Cardioangiol. 2008 Aug;56(4):391-9.

PMID:
18614983
9.

The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.

Engström AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, de Jong M, Lagrand WK, van der Sloot JA, Tijssen JG, de Winter RJ, de Mol BA, Piek JJ, Henriques JP.

Crit Care Med. 2011 Sep;39(9):2072-9. doi: 10.1097/CCM.0b013e31821e89b5.

PMID:
21602670
10.

Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.

Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W.

Thorac Cardiovasc Surg. 2003 Dec;51(6):312-7.

PMID:
14669126
11.

Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.

Bresson D, Sibellas F, Farhat F, Jegaden O, Kirkorian G, Bonnefoy E.

Arch Cardiovasc Dis. 2011 Aug;104(8-9):458-64. doi: 10.1016/j.acvd.2011.04.005. Epub 2011 Aug 27.

12.

Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and IMPELLA Recover LP2.5.

Manzo-Silberman S, Fichet J, Mathonnet A, Varenne O, Ricome S, Chaib A, Zuber B, Spaulding C, Cariou A.

Resuscitation. 2013 May;84(5):609-15. doi: 10.1016/j.resuscitation.2012.10.001. Epub 2012 Oct 13.

PMID:
23069592
13.

The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support.

Griffith BP, Anderson MB, Samuels LE, Pae WE Jr, Naka Y, Frazier OH.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):548-54. doi: 10.1016/j.jtcvs.2012.01.067. Epub 2012 Mar 9.

14.

Microaxial devices for ventricular failure: a multicentre, population-based experience.

Higgins J, Lamarche Y, Kaan A, Stevens LM, Cheung A.

Can J Cardiol. 2011 Nov-Dec;27(6):725-30. doi: 10.1016/j.cjca.2011.02.002. Epub 2011 Oct 8.

PMID:
21983112
15.

The Impella® Recover mechanical assist device in acute cardiogenic shock: a single-centre experience of 66 patients.

Schiller P, Vikholm P, Hellgren L.

Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):452-8. doi: 10.1093/icvts/ivv305. Epub 2016 Jan 12.

PMID:
26763043
16.

Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.

Guenther S, Theiss HD, Fischer M, Sattler S, Peterss S, Born F, Pichlmaier M, Massberg S, Hagl C, Khaladj N.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):283-91. doi: 10.1093/icvts/ivt505. Epub 2013 Dec 13.

17.

Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.

Engström AE, Granfeldt H, Seybold-Epting W, Dahm M, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, Koch KT, De Jong M, Lagrand WK, Van Der Sloot JA, Tijssen JG, De Winter RJ, De Mol BA, Piek JJ, Henriques JP.

Minerva Cardioangiol. 2013 Oct;61(5):539-46.

PMID:
24096248
18.

Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.

Mastroianni C, Bouabdallaoui N, Leprince P, Lebreton G.

Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):87-92. doi: 10.1177/2048872616633877. Epub 2016 Sep 20.

PMID:
26873912
19.

Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.

Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW.

Eur Heart J. 2009 Sep;30(17):2102-8. doi: 10.1093/eurheartj/ehp292. Epub 2009 Jul 18. Review.

PMID:
19617601
20.

The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.

Casassus F, Corre J, Leroux L, Chevalereau P, Fresselinat A, Seguy B, Calderon J, Coste P, Ouattara A, Roques X, Barandon L.

J Interv Cardiol. 2015 Feb;28(1):41-50. doi: 10.1111/joic.12172.

PMID:
25689547

Supplemental Content

Support Center